Microencapsulated Vaccinium floribundum Kunth extract promotes angiogenesis and attenuates inflammation in in vitro and in vivo models.

This study demonstrates that a microencapsulated extract of *Vaccinium floribundum*, rich in bioactive polyphenols, effectively promotes angiogenesis and attenuates inflammation in both endothelial cell cultures and a mouse edema model, supporting its potential as a therapeutic agent for vascular and inflammatory disorders.

The Gist

The Big Idea: A Super-Berry with a Secret Armor

Imagine you have a magical berry from the high mountains of Ecuador called Mortiño (Vaccinium floribundum). In the local culture, people have eaten this berry for centuries to stay healthy. Scientists wanted to know: Is this berry actually a medicine, and can we use it to fix broken blood vessels or stop inflammation?

The problem is that these berries are like delicate glass sculptures. If you try to eat them or put them in a pill, the heat, light, and stomach acid can break them down before they reach your bloodstream. They lose their power.

The Solution: The researchers put the berry extract inside a tiny, protective "bubble" made of a safe starch called microencapsulation. Think of this like putting a fragile, precious gem inside a reinforced steel safe. This safe protects the berry's power while it travels through the body, ensuring it arrives at the destination intact and ready to work.

---

Part 1: The "Construction Crew" (Angiogenesis)

The Goal: To see if the berry helps build new blood vessels.

The Analogy: Imagine your body is a city, and your blood vessels are the roads. Sometimes, roads get damaged or need to be expanded to handle more traffic (like when healing a wound). You need a construction crew to build new roads.

What They Did:
They took a sample of the berry "safe" (the microencapsulated extract) and gave it to a team of "road builders" (endothelial cells) in a petri dish.

The Result:

• The Berry Boosted the Crew: The berry didn't just keep the builders alive; it made them more energetic.
• Better Roads: When they looked at the cells under a microscope, the treated cells built a much more complex and connected network of "roads" (capillaries) than the untreated ones.
• The Switch: The berry flipped a specific "start button" (a gene called FLT-1) in the cells, telling them, "Hey, it's time to start building!"

Translation: The berry extract helps your body grow new, healthy blood vessels, which is crucial for healing wounds and keeping your heart healthy.

---

Part 2: The "Firefighters" (Inflammation)

The Goal: To see if the berry can stop inflammation (swelling and pain).

The Analogy: Imagine your blood vessels are a peaceful neighborhood. Suddenly, a bad guy (a bacteria toxin called LPS) shows up and starts a fire. The neighborhood panics, the police (immune cells) arrive, and the whole area gets red, hot, and swollen. This is inflammation.

What They Did:
They set the "fire" in the petri dish using the bad guy (LPS). Then, they threw the berry "fire extinguisher" (the extract) at the scene.

The Result:

• Saving the Neighborhood: Without the berry, the fire killed many of the road builders. With the berry, the buildings stayed standing.
• Quieting the Panic: The fire usually makes the neighborhood scream for help (releasing inflammatory signals like IL-6 and IL-8). The berry extract turned down the volume on these screams. It told the cells, "Calm down, we don't need to panic."

Translation: The berry extract protects your blood vessels from damage caused by infections or toxins and calms down the body's overreaction (inflammation).

---

Part 3: The "Mouse Test" (In Vivo)

The Goal: To see if this works in a real living animal, not just in a dish.

The Analogy: Imagine a mouse has a swollen, red paw (like a bee sting). Scientists want to see if the berry safe can shrink the swelling.

What They Did:
They gave mice a substance that causes a swollen paw. Then, they gave some mice the berry extract (in three different doses) and one group a standard painkiller (Diclofenac) to compare.

The Result:
The mice that got the highest dose of the berry extract had paws that were almost as good as the mice that got the strong medicine. The swelling went down significantly.

Translation: The berry works in real life, not just in a lab dish. It's as effective as common anti-inflammatory drugs at reducing swelling.

---

The "Secret Sauce" (What's Inside?)

The scientists analyzed the berry and found it was packed with polyphenols and anthocyanins (the stuff that makes berries blue/purple).

• Chlorogenic Acid & Quercetin: These were the heavy hitters, acting like the main firefighters.
• The Microencapsulation: This was the key. By wrapping the berry in that starch "safe," the scientists made sure these chemicals didn't break down. It's like the difference between throwing a wet match into a fire (regular extract) versus lighting a firework (microencapsulated extract)—the firework lasts longer and hits harder.

The Bottom Line

This study proves that the Mortiño berry from Ecuador is a powerful natural tool.

1. It helps build new blood vessels (great for healing).
2. It calms inflammation (great for pain and swelling).
3. Microencapsulation is the secret trick that makes it work better than just eating the raw berry.

Why it matters: This supports the traditional wisdom of Ecuadorian communities and suggests that in the future, we might have new, natural medicines made from these berries to help treat heart disease, slow-healing wounds, and chronic inflammation, all while being safer and more stable than current synthetic drugs.

Technical Summary

Title

Microencapsulated Vaccinium floribundum Kunth extract promotes angiogenesis and attenuates inflammation in in vitro and in vivo models.

1. Problem Statement

Natural products, particularly polyphenol-rich medicinal plants, are increasingly sought after as multitarget therapeutics for angiogenic regeneration and inflammatory diseases. However, bioactive compounds often suffer from poor stability, low bioavailability, and uncontrolled release. Furthermore, there is a need to scientifically validate the traditional use of specific Ecuadorian flora, such as Vaccinium floribundum (mortiño), using rigorous preclinical models that bridge the gap between cellular mechanisms and systemic physiological responses.

2. Methodology

The study employed a comprehensive approach combining phytochemical characterization, in vitro cellular assays, and an in vivo animal model.

• Plant Material & Extraction: Fruits of Vaccinium floribundum were collected in the Andean highlands of Ecuador. They were dried, crushed, and extracted using a 50:50 ethanol:water maceration method.
• Microencapsulation: The ethanolic extract (VFE) was microencapsulated using maltodextrin (10–20 DE) as a carrier via spray drying (inlet temp: 140°C; outlet temp: 80°C). The resulting microcapsules (VFM) were characterized for yield and structural integrity using FTIR spectroscopy.
• Phytochemical Analysis:
  • HPLC-DAD: Quantified phenolic acids and flavonoids.
  • HPLC-MS: Identified and quantified anthocyanins.
• In Vitro Models (Porcine Aortic Endothelial Cells - pAECs):
  • Cell Viability: MTT assay to assess cytotoxicity and metabolic activity at various VFM concentrations (1 ng/mL to 1 mg/mL).
  • Angiogenesis: Capillary-like tube formation assay on GelTrex™ matrix.
  • Gene Expression (qPCR): Analysis of angiogenic markers (VEGF, FLT-1, FLK-1, HO-1) and inflammatory cytokines (IL-6, IL-8) at 5h and 24h.
  • Inflammatory Challenge: Cells were treated with Lipopolysaccharide (LPS, 25 µg/mL) to induce dysfunction, with and without VFM co-treatment.
• In Vivo Model:
  • Carrageenan-Induced Paw Edema: Male Balb/c mice were divided into control, negative (carrageenan), positive (diclofenac), and experimental groups (VFM at 75, 150, and 300 mg/kg). Paw volume was measured over 6 hours to calculate inflammation inhibition.

3. Key Contributions

• Development of a Stable Formulation: Successfully developed a microencapsulated formulation (VFM) of V. floribundum extract, achieving a 75.97% encapsulation yield. FTIR analysis confirmed successful entrapment of polyphenols within the maltodextrin matrix via hydrogen bonding.
• Comprehensive Phytochemical Profiling: Identified 15 bioactive compounds, establishing a rich profile dominated by chlorogenic acid (13.21 ppm), quercetin (5.29 ppm), and procyanidin B1 (5.94 ppm), alongside specific anthocyanins (ideain and petunidin).
• Dual-Action Validation: Provided scientific evidence that the extract acts as both a pro-angiogenic agent (promoting vascular network formation) and an anti-inflammatory agent (protecting against LPS-induced damage and reducing acute edema).
• Integration of Models: Demonstrated the efficacy of combining primary porcine endothelial cells (mimicking human vascular physiology) with murine acute inflammation models to evaluate translational potential.

4. Key Results

• Phytochemistry: The extract contained a diverse array of flavonoids, procyanidins, and phenolic acids. Chlorogenic acid was the most abundant metabolite, followed by quercetin and procyanidin B1.
• Cell Viability & Angiogenesis:
  • VFM (up to 1 mg/mL) was non-toxic and significantly increased endothelial cell viability compared to controls.
  • Tube Formation: VFM treatment significantly enhanced the formation of capillary-like networks, increasing master junctions, segment length, and mesh area.
  • Gene Expression: A transient upregulation of FLT-1 (VEGFR-1) was observed at 5 hours, suggesting VFM triggers early angiogenic signaling. By 24 hours, gene levels returned to baseline, indicating a rapid signaling cascade.
• Anti-Inflammatory Effects (In Vitro):
  • LPS exposure significantly reduced cell viability and upregulated IL-6 and IL-8.
  • Co-treatment with VFM (1 mg/mL) restored cell viability to basal levels and significantly downregulated IL-6 and IL-8 mRNA expression, mitigating LPS-induced endothelial dysfunction.
• Anti-Inflammatory Effects (In Vivo):
  • In the carrageenan paw edema model, the highest dose of VFM (300 mg/kg) achieved an inflammation inhibition of 50.63%, which was statistically comparable to the positive control, diclofenac (51.74%).
  • The microencapsulated form showed sustained efficacy, likely due to controlled release of bioactive compounds.

5. Significance

• Scientific Validation of Ethnomedicine: The study validates the traditional use of Vaccinium floribundum (mortiño) in Ecuadorian culture, confirming its pharmacological potential for vascular and inflammatory disorders.
• Therapeutic Potential: The findings suggest VFM is a promising candidate for developing nutraceuticals targeting:
  • Vascular Repair: Supporting angiogenesis in ischemic tissues or wound healing.
  • Inflammatory Management: Treating acute and chronic inflammatory conditions via cytokine modulation and oxidative stress reduction.
• Formulation Advancement: The success of microencapsulation highlights its critical role in preserving the stability and bioavailability of sensitive polyphenols, making them viable for clinical or commercial applications.
• Sustainable Resource Use: The research supports the sustainable utilization of Ecuador's biodiversity, offering a pathway for economic development through the valorization of native medicinal plants.

Conclusion: The microencapsulated Vaccinium floribundum extract is a potent, dual-function therapeutic agent that promotes vascular health and suppresses inflammation, bridging traditional knowledge with modern pharmaceutical formulation strategies.